The global assisted reproductive technology market was valued at USD 21.32 billion in 2018 and is expected to reach USD 45.06 billion by 2026, growing at a CAGR of 9.8%. The U.S. is experiencing significant market growth, driven by rising infertility rates, advancements in medical technologies, and increased awareness of reproductive treatments. In 2018, Europe led the global market with a share of 41.18%.

Assisted reproductive technologies (ART)—including in-vitro fertilization (IVF), artificial insemination (AI-IUI), frozen embryo transfer (FET), and gamete intrafallopian transfer (GIFT)—are becoming increasingly popular solutions for addressing infertility. The rising incidence of infertility, driven by factors such as lifestyle changes, elevated stress levels, and delayed parenthood, has significantly boosted the demand for ART. Technological advancements, particularly in procedures like intracytoplasmic sperm injection (ICSI) and FET, have led to improved clinical outcomes, further fueling market growth.

Despite these advancements, several challenges hinder the widespread adoption of ART. High treatment costs, especially in developing countries, continue to limit accessibility for many individuals. Additionally, socio-ethical concerns and low awareness in certain regions pose further barriers to adoption. Nevertheless, growing government support and educational initiatives are gradually improving awareness and acceptance, making ART services more accessible on a global scale.

Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/assisted-reproductive-technology-art-market-101811

Assisted Reproductive Technology Market Trends:

The rising prevalence of infertility in countries like China, the U.S., the U.K., and India is significantly fueling the demand for assisted reproductive technologies (ART). In 2018, around 6.7% of women aged 15–44 in the U.S. faced infertility, with male infertility also becoming increasingly common. Key contributing factors include sedentary lifestyles, elevated stress levels, and obesity. In response, governments and non-profit organizations across both developed and developing regions are actively working to improve the accessibility and affordability of fertility treatments, further accelerating market growth.

List Of Top Assisted Reproductive Technology Market Companies:

• Bloom IVF Centre
• California Cryobank
• CARE Fertility
• Monash IVF Group
• Carolinas Fertility Institute
• European Sperm Bank
• INVO Bioscience
• Apollo Hospitals Enterprise Ltd.
• Other Players

Assisted Reproductive Technology Market Segmentation:

By Technique Outlook
In vitro fertilization (IVF) dominated the ART market in 2018, fueled by its high success rates and continuous technological advancements, including time-lapse imaging systems that allow precise embryo monitoring. These innovations are expected to further boost IVF adoption. Frozen embryo transfer (FET) emerged as the second-largest segment, offering a cost-effective alternative with high success rates and faster outcomes compared to fresh IVF cycles. Other techniques such as gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT) are also gaining popularity due to their proven clinical effectiveness.

By Procedure Outlook

The fresh non-donor procedure is expected to register the highest compound annual growth rate (CAGR), driven by its strong success rates and the rising incidence of infertility. Research shows a 19% live birth rate for fresh egg-based cycles, underscoring its effectiveness. Frozen non-donor procedures hold the second-largest share, favored for their affordability and efficiency. Additionally, fresh donor and frozen donor procedures are projected to grow steadily, supported by advancements in cryopreservation and increasing acceptance of donor-based reproductive treatments.

By End-User Outlook
Fertility clinics led the ART market in 2018 and are poised to retain their lead, thanks to the rising number of specialized procedures and skilled medical professionals. This segment is expected to grow particularly fast in emerging markets such as China, India, and Japan, where demand for ART services continues to rise. Hospitals, while contributing a smaller share, are growing more slowly due to limited adoption of advanced ART techniques and less specialized care.

Assisted Reproductive Technology Market Regional Analysis

In 2018, Europe held the largest share of the ART market, generating around USD 8.78 billion in revenue. The region’s dominance is attributed to strong demand for fertility treatments in countries such as Spain, Denmark, the U.K., Germany, and France. Europe's advanced healthcare systems and supportive regulatory frameworks continue to support market leadership.

North America is expected to witness substantial growth, driven by rising adoption of fertility treatments and higher disposable income levels, particularly in the United States. The presence of numerous fertility clinics and ongoing technological innovation are also key growth contributors.

The Asia Pacific region is forecasted to experience the highest growth rate through 2026. Increasing infertility rates, growing awareness of ART procedures, and declining social stigmas—particularly in India, China, Australia, and Japan—are driving market expansion. Enhanced healthcare infrastructure and a rise in medical tourism further support growth in this region.

Latin America and the Middle East & Africa are projected to show moderate growth. Improvements in healthcare systems, coupled with increasing infertility rates and broader acceptance of ART, are gradually advancing these regional markets.

Key Industry Development:

In April 2019, Silverfleet Capital Partners acquired a significant stake in CARE Fertility to diversify its product portfolio and enhance its market position.